Clinical Trials Logo

Severe Postpartum Depression clinical trials

View clinical trials related to Severe Postpartum Depression.

Filter by:
  • None
  • Page 1

NCT ID: NCT06057012 Completed - Clinical trials for Severe Postpartum Depression

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

Start date: September 29, 2023
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to evaluate the safety and tolerability of BRII-296 administered by 2 intramuscular injections, administered with Depo Medrol as assessed by the incidence of adverse events, changes from baseline in vital signs, pulse oximetry, clinical laboratory evaluations, electrocardiograms (ECGs), Stanford Sleepiness Scale (SSS), Glasgow Coma Scale (GCS) in conjunction with clinical assessment, and suicidal ideation using the Columbia Suicide Severity Rating Scale (C-SSRS).

NCT ID: NCT02614547 Completed - Clinical trials for Severe Postpartum Depression

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Start date: December 15, 2015
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.